These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26469548)

  • 21. Simultaneous determination of aromatic and chlorinated compounds in urine of exposed workers by dynamic headspace and gas chromatography coupled to mass spectrometry (dHS-GC-MS).
    Erb A; Marsan P; Burgart M; Remy A; Lambert-Xolin AM; Jeandel F; Hanser O; Robert A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep; 1125():121724. PubMed ID: 31352201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
    Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
    Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of volatile organic compounds exhaled by cell lines derived from hematological malignancies.
    Tang H; Lu Y; Zhang L; Wu Z; Hou X; Xia H
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28507202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of volatile components in four vegetable oils by headspace two-dimensional comprehensive chromatography time-of-flight mass spectrometry.
    Hu W; Zhang L; Li P; Wang X; Zhang Q; Xu B; Sun X; Ma F; Ding X
    Talanta; 2014 Nov; 129():629-35. PubMed ID: 25127643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of volatile organic compounds for the classification and identification of mycobacterial species.
    Küntzel A; Oertel P; Fischer S; Bergmann A; Trefz P; Schubert J; Miekisch W; Reinhold P; Köhler H
    PLoS One; 2018; 13(3):e0194348. PubMed ID: 29558492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening of volatile organic compounds (VOCs) from liquid fungal cultures using ambient mass spectrometry.
    Heffernan D; Pilz M; Klein M; Haack M; Race AM; Brück T; Qoura F; Strittmatter N
    Anal Bioanal Chem; 2023 Jul; 415(18):4615-4627. PubMed ID: 37389599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discrimination of bacteria by rapid sensing their metabolic volatiles using an aspiration-type ion mobility spectrometer (a-IMS) and gas chromatography-mass spectrometry GC-MS.
    Ratiu IA; Bocos-Bintintan V; Patrut A; Moll VH; Turner M; Thomas CLP
    Anal Chim Acta; 2017 Aug; 982():209-217. PubMed ID: 28734362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
    Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
    J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solvent Extraction of PDMS Tubing as a New Method for the Capture of Volatile Organic Compounds from Headspace.
    Thomas G; Caulfield J; Nikolaeva-Reynolds L; Birkett MA; Vuts J
    J Chem Ecol; 2024 Apr; 50(3-4):85-99. PubMed ID: 38246946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of volatile organic compounds (VOCs) in the headspace of NCI-H1666 lung cancer cells.
    Sponring A; Filipiak W; Ager C; Schubert J; Miekisch W; Amann A; Troppmair J
    Cancer Biomark; 2010; 7(3):153-61. PubMed ID: 21263191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rapid method for the chromatographic analysis of volatile organic compounds in exhaled breath of tobacco cigarette and electronic cigarette smokers.
    Marco E; Grimalt JO
    J Chromatogr A; 2015 Sep; 1410():51-9. PubMed ID: 26243705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Volatile organic compounds at swine facilities: a critical review.
    Ni JQ; Robarge WP; Xiao C; Heber AJ
    Chemosphere; 2012 Oct; 89(7):769-88. PubMed ID: 22682363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The versatile use of exhaled volatile organic compounds in human health and disease.
    Boots AW; van Berkel JJ; Dallinga JW; Smolinska A; Wouters EF; van Schooten FJ
    J Breath Res; 2012 Jun; 6(2):027108. PubMed ID: 22621865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved quantification of livestock associated odorous volatile organic compounds in a standard flow-through system using solid-phase microextraction and gas chromatography-mass spectrometry.
    Yang X; Zhu W; Koziel JA; Cai L; Jenks WS; Laor Y; Leeuwen JH; Hoff SJ
    J Chromatogr A; 2015 Oct; 1414():31-40. PubMed ID: 26456221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exhaled volatile organic compounds predict exacerbations of childhood asthma in a 1-year prospective study.
    Robroeks CM; van Berkel JJ; Jöbsis Q; van Schooten FJ; Dallinga JW; Wouters EF; Dompeling E
    Eur Respir J; 2013 Jul; 42(1):98-106. PubMed ID: 23645402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
    Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
    J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic intestinal Mycobacteria infection: discrimination via VOC analysis in exhaled breath and headspace of feces using differential ion mobility spectrometry.
    Purkhart R; Köhler H; Liebler-Tenorio E; Meyer M; Becher G; Kikowatz A; Reinhold P
    J Breath Res; 2011 Jun; 5(2):027103. PubMed ID: 21512209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolomics of volatile organic compounds in cystic fibrosis patients and controls.
    Robroeks CM; van Berkel JJ; Dallinga JW; Jöbsis Q; Zimmermann LJ; Hendriks HJ; Wouters MF; van der Grinten CP; van de Kant KD; van Schooten FJ; Dompeling E
    Pediatr Res; 2010 Jul; 68(1):75-80. PubMed ID: 20351658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breath volatile organic compounds of lung transplant recipients with and without chronic lung allograft dysfunction.
    Küppers L; Holz O; Schuchardt S; Gottlieb J; Fuge J; Greer M; Hohlfeld JM
    J Breath Res; 2018 Jun; 12(3):036023. PubMed ID: 29771243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.